Axiom awarded multiple contracts

Studies will use Fusion eClinical Suite’s IWRS Module

Register for free to listen to this article
Listen with Speechify
0:00
5:00
TORONTO—Axiom Real-Time Metrics, a provider of unified eClinical solutions and services, has been awarded three new studies using its Fusion eClinical Suite’s IWRS Module.
 
As one of the core modules of Axiom’s Fusion eClinical Suite, the IWRS module boasts many key features, including the ability to manage drug supply across an entire group of studies, plus a range of real-time dashboards to track drug supply, pending shipments and upcoming site needs.
 
“Fusion eClinical Suite empowers organizations to manage every aspect of their clinical trials. This truly unified product platform offering is unique in the industry with every component built by Axiom engineers, allowing sponsors to benefit from our agile development, intuitive design and feature-rich technology that is highly configurable and end user-focused to all key stakeholders in the process,” said Andrew Schachter, Axiom’s CEO and founder. “We are thrilled to be working with small to mid-sized biotech and medical device companies to solve their IWRS/RTSM [interactive web response systems/randomization and trial supply management] challenges, and look forward to supporting our clients on these new studies.”
 
Added Heather Di Fruscia, associate director of IWRS/RTSM: “Fusion’s capacity for automated predictive resupply via AI technology that analyzes all site data and determines overall site needs allows our clients to focus on other important study details instead of worrying about sufficient inventory for upcoming subject visits. Overall, our strategic, study specific approach to planning, design and implementation ensures that our clients and their inventory are well taken care of.”


Published In:


Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

DDN Magazine May 2024

Latest Issue  

• Volume 20 • Issue 3 • May 2024

May 2024

May 2024 Issue